{"id":10467,"date":"2025-05-13T09:45:11","date_gmt":"2025-05-13T09:45:11","guid":{"rendered":"https:\/\/www.ixa.nl\/?post_type=article&p=10467"},"modified":"2026-06-24T13:21:15","modified_gmt":"2026-06-24T13:21:15","slug":"azafaros","status":"publish","type":"article","link":"https:\/\/www.ixa.nl\/nl\/news\/azafaros\/","title":{"rendered":"Amsterdam UMC spin-off Azafaros haalt \u20ac132M op in overtekend Serie B om Fase 3 therapie\u00ebn voor zeldzame aandoeningen te bevorderen"},"excerpt":{"rendered":"

Azafaros, een bedrijf in de klinische fase dat zich richt op de ontwikkeling van ziekte-modificerende therapie\u00ebn om nieuwe behandelingsopties te bieden aan pati\u00ebnten met zeldzame lysosomale stapelingsziekten, kondigt de voltooiing aan van een overtekende Serie B-financiering van \u20ac 132 miljoen onder leiding van Jeito Capital, mede geleid door Forbion Growth en met aanvullende deelname van Seroba, Pictet Group en bestaande investeerders Forbion Ventures, Schroders Capital en BioGeneration Ventures (BGV).<\/p>\n","protected":false},"featured_media":6360,"template":"","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","inline_featured_image":false},"categories":[],"tags":[],"knowledge-institution":[],"class_list":["post-10467","article","type-article","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\nAmsterdam UMC spin-off Azafaros haalt \u20ac132M op in overtekend Serie B om Fase 3 therapie\u00ebn voor zeldzame aandoeningen te bevorderen - IXA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ixa.nl\/nl\/news\/azafaros\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Amsterdam UMC spin-off Azafaros haalt \u20ac132M op in overtekend Serie B om Fase 3 therapie\u00ebn voor zeldzame aandoeningen te bevorderen - IXA\" \/>\n<meta property=\"og:description\" content=\"Azafaros, een bedrijf in de klinische fase dat zich richt op de ontwikkeling van ziekte-modificerende therapie\u00ebn om nieuwe behandelingsopties te bieden aan pati\u00ebnten met zeldzame lysosomale stapelingsziekten, kondigt de voltooiing aan van een overtekende Serie B-financiering van \u20ac 132 miljoen onder leiding van Jeito Capital, mede geleid door Forbion Growth en met aanvullende deelname van Seroba, Pictet Group en bestaande investeerders Forbion Ventures, Schroders Capital en BioGeneration Ventures (BGV).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ixa.nl\/nl\/news\/azafaros\/\" \/>\n<meta property=\"og:site_name\" content=\"IXA\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-24T13:21:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ixa.nl\/app\/uploads\/2025\/04\/Beeld_Azafaros_scientific_approach2-2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ixa.nl\\\/nl\\\/news\\\/azafaros\\\/\",\"url\":\"https:\\\/\\\/www.ixa.nl\\\/nl\\\/news\\\/azafaros\\\/\",\"name\":\"Amsterdam UMC spin-off Azafaros haalt \u20ac132M op in overtekend Serie B om Fase 3 therapie\u00ebn voor zeldzame aandoeningen te bevorderen - IXA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ixa.nl\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.ixa.nl\\\/nl\\\/news\\\/azafaros\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ixa.nl\\\/nl\\\/news\\\/azafaros\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ixa.nl\\\/app\\\/uploads\\\/2025\\\/04\\\/Beeld_Azafaros_scientific_approach2-2.jpg\",\"datePublished\":\"2025-05-13T09:45:11+00:00\",\"dateModified\":\"2026-06-24T13:21:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ixa.nl\\\/nl\\\/news\\\/azafaros\\\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ixa.nl\\\/nl\\\/news\\\/azafaros\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.ixa.nl\\\/nl\\\/news\\\/azafaros\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.ixa.nl\\\/app\\\/uploads\\\/2025\\\/04\\\/Beeld_Azafaros_scientific_approach2-2.jpg\",\"contentUrl\":\"https:\\\/\\\/www.ixa.nl\\\/app\\\/uploads\\\/2025\\\/04\\\/Beeld_Azafaros_scientific_approach2-2.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ixa.nl\\\/nl\\\/news\\\/azafaros\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.ixa.nl\\\/nl\\\/homepage\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Amsterdam UMC spin-off Azafaros haalt \u20ac132M op in overtekend Serie B om Fase 3 therapie\u00ebn voor zeldzame aandoeningen te bevorderen\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ixa.nl\\\/#website\",\"url\":\"https:\\\/\\\/www.ixa.nl\\\/\",\"name\":\"IXA\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ixa.nl\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Amsterdam UMC spin-off Azafaros haalt \u20ac132M op in overtekend Serie B om Fase 3 therapie\u00ebn voor zeldzame aandoeningen te bevorderen - IXA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ixa.nl\/nl\/news\/azafaros\/","og_locale":"nl_NL","og_type":"article","og_title":"Amsterdam UMC spin-off Azafaros haalt \u20ac132M op in overtekend Serie B om Fase 3 therapie\u00ebn voor zeldzame aandoeningen te bevorderen - IXA","og_description":"Azafaros, een bedrijf in de klinische fase dat zich richt op de ontwikkeling van ziekte-modificerende therapie\u00ebn om nieuwe behandelingsopties te bieden aan pati\u00ebnten met zeldzame lysosomale stapelingsziekten, kondigt de voltooiing aan van een overtekende Serie B-financiering van \u20ac 132 miljoen onder leiding van Jeito Capital, mede geleid door Forbion Growth en met aanvullende deelname van Seroba, Pictet Group en bestaande investeerders Forbion Ventures, Schroders Capital en BioGeneration Ventures (BGV).","og_url":"https:\/\/www.ixa.nl\/nl\/news\/azafaros\/","og_site_name":"IXA","article_modified_time":"2026-06-24T13:21:15+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/www.ixa.nl\/app\/uploads\/2025\/04\/Beeld_Azafaros_scientific_approach2-2.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ixa.nl\/nl\/news\/azafaros\/","url":"https:\/\/www.ixa.nl\/nl\/news\/azafaros\/","name":"Amsterdam UMC spin-off Azafaros haalt \u20ac132M op in overtekend Serie B om Fase 3 therapie\u00ebn voor zeldzame aandoeningen te bevorderen - IXA","isPartOf":{"@id":"https:\/\/www.ixa.nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ixa.nl\/nl\/news\/azafaros\/#primaryimage"},"image":{"@id":"https:\/\/www.ixa.nl\/nl\/news\/azafaros\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ixa.nl\/app\/uploads\/2025\/04\/Beeld_Azafaros_scientific_approach2-2.jpg","datePublished":"2025-05-13T09:45:11+00:00","dateModified":"2026-06-24T13:21:15+00:00","breadcrumb":{"@id":"https:\/\/www.ixa.nl\/nl\/news\/azafaros\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ixa.nl\/nl\/news\/azafaros\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.ixa.nl\/nl\/news\/azafaros\/#primaryimage","url":"https:\/\/www.ixa.nl\/app\/uploads\/2025\/04\/Beeld_Azafaros_scientific_approach2-2.jpg","contentUrl":"https:\/\/www.ixa.nl\/app\/uploads\/2025\/04\/Beeld_Azafaros_scientific_approach2-2.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/www.ixa.nl\/nl\/news\/azafaros\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ixa.nl\/nl\/homepage\/"},{"@type":"ListItem","position":2,"name":"Amsterdam UMC spin-off Azafaros haalt \u20ac132M op in overtekend Serie B om Fase 3 therapie\u00ebn voor zeldzame aandoeningen te bevorderen"}]},{"@type":"WebSite","@id":"https:\/\/www.ixa.nl\/#website","url":"https:\/\/www.ixa.nl\/","name":"IXA","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ixa.nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"}]}},"_links":{"self":[{"href":"https:\/\/www.ixa.nl\/nl\/wp-json\/wp\/v2\/article\/10467","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ixa.nl\/nl\/wp-json\/wp\/v2\/article"}],"about":[{"href":"https:\/\/www.ixa.nl\/nl\/wp-json\/wp\/v2\/types\/article"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ixa.nl\/nl\/wp-json\/wp\/v2\/media\/6360"}],"wp:attachment":[{"href":"https:\/\/www.ixa.nl\/nl\/wp-json\/wp\/v2\/media?parent=10467"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ixa.nl\/nl\/wp-json\/wp\/v2\/categories?post=10467"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ixa.nl\/nl\/wp-json\/wp\/v2\/tags?post=10467"},{"taxonomy":"knowledge-institution","embeddable":true,"href":"https:\/\/www.ixa.nl\/nl\/wp-json\/wp\/v2\/knowledge-institution?post=10467"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}